![]() |
CiteULike | ![]() |
jfr's CiteULike | ![]() |
![]() |
|
![]() |
Register | ![]() |
Log in | ![]() |
The colorectal cancer risk at 18q21 is caused by a novel variant altering SMAD7 expression |
Reviews
[Write a review of this article]
Find related articles from these CiteULike users
Find related articles with these CiteULike tags
Posting History
Abstract10.1101/gr.092668.109 Recent genome-wide scans for colorectal cancer (CRC) have revealed the (others gainst ecapentaplegic homolog ) gene as a locus associated with a modest, but highly significant increase in CRC risk. To identify the causal basis of the association between 18q21 variation and CRC, we resequenced the 17-kb region of linkage disequilibrium and evaluated all variants in 2532 CRC cases and 2607 controls. A novel C to G single nucleotide polymorphism (SNP) at 44,703,563 bp was maximally associated with CRC risk ( = 5.98 × 10; ≥1.5-fold more likely to be causal than other variants). Using transgenic assays in as a functional model, we demonstrate that the G risk allele leads to reduced reporter gene expression in the colorectum ( = 5.4 × 10). Electrophoretic mobility shift assays provided evidence for the role of Novel 1 in transcription factor binding. We propose that the novel SNP we have identified is the functional change leading to CRC predisposition through differential expression and, hence, aberrant TGF-beta signaling.
BibTeX record
RIS record